...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Share transfer RBC
1
May 01, 2019 10:56PM
1
May 02, 2019 08:21AM
2
May 02, 2019 10:40AM
2
May 02, 2019 04:23PM

May 03, 2019 07:49AM
1
May 03, 2019 08:46AM
2
May 03, 2019 10:17AM

I would agree that  FMV is more expensive, but also more appropriate with the shares not publicly traded! I have complained vigorously to Zenith that they need to do more to support shareholders!

2
May 03, 2019 01:33PM
Share
New Message
Please login to post a reply